Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

Condition:   Pancreatic Ductal Adenocarcinoma Interventions:   Radiation: Stereotactic body radiotherapy (SBRT);   Drug: Zimberelimab;   Drug: Quemliclustat;   Drug: Etrumadenant;   Drug: Modified FOLFIRINOX Sponsors:   Gulam Manji;   Arcus Biosciences, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials